Amgen
AMGN
#105
Rank
$141.57 B
Marketcap
$263.38
Share price
0.84%
Change (1 day)
-4.29%
Change (1 year)

The biotechnology company Amgen was founded in 1980 as AMGen. With approximately 20,000 employees, Amgen is one of the world's largest biotechnology companies with annual sales of approximately $ 24 billion in 2018.

Amgen (AMGN) - Total debt

Total debt on the balance sheet as of September 2024 : $60.39 Billion USD

According to Amgen's latest financial reports the company's total debt is $60.39 Billion USD. A companyโ€™s total debt is the sum of all current and non-current debts.

Amgen - Total debt on balance sheet (from 1996 to 2024)

Total debt by year

Year Total debt Change
2023-12-31$64.61 B65.91%
2022-12-31$38.94 B16.92%
2021-12-31$33.30 B0.98%
2020-12-31$32.98 B10.31%
2019-12-31$29.90 B-11.87%
2018-12-31$33.92 B-4%
2017-12-31$35.34 B2.16%
2016-12-31$34.59 B10.08%
2015-12-31$31.42 B2.32%
2014-12-31$30.71 B-4.4%
2013-12-31$32.12 B21.11%
2012-12-31$26.52 B23.81%
2011-12-31$21.42 B60.37%
2010-12-31$13.36 B26.04%
2009-12-31$10.60 B4.18%
2008-12-31$10.17 B-8.96%
2007-12-31$11.17 B24.02%
2006-12-31$9.01 B127.75%
2005-12-31$3.95 B-22.56%
2004-12-31$5.11 B65.91%
2003-12-31$3.08 B-2.87%
2002-12-31$3.17 B882.04%
2001-12-31$0.32 B0.06%
2000-12-31$0.32 B0.06%
1999-12-31$0.32 B-1.89%
1998-12-31$0.32 B26.91%
1997-12-31$0.25 B46.16%
1996-12-31$0.17 B

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
$66.61 B 10.30%๐Ÿ‡บ๐Ÿ‡ธ USA
$51.40 B-14.90%๐Ÿ‡บ๐Ÿ‡ธ USA
$21.49 B-64.42%๐Ÿ‡ฌ๐Ÿ‡ง UK
$23.24 B-61.51%๐Ÿ‡บ๐Ÿ‡ธ USA
$6.65 B-88.99%๐Ÿ‡บ๐Ÿ‡ธ USA
$71.07 B 17.68%๐Ÿ‡บ๐Ÿ‡ธ USA
$35.75 B-40.81%๐Ÿ‡บ๐Ÿ‡ธ USA
$2.67 B-95.57%๐Ÿ‡บ๐Ÿ‡ธ USA
$31.11 B-48.48%๐Ÿ‡บ๐Ÿ‡ธ USA